Tolerability and pharmacokinetics of single ascending doses of AFN 1252 in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 02 May 2012
At a glance
- Drugs Debio 1452 (Primary)
- Indications Bacterial infections; Skin and soft tissue infections
- Focus Adverse reactions
- Sponsors Affinium Pharmaceuticals
- 02 May 2012 Status changed from recruiting to completed.
- 07 Mar 2008 New trial record.